[SCHEDULE 13G/A] Biophytis SA Amended Passive Investment Disclosure
BlackRock unit reports 4.8% stake in Biophytis
Biophytis SA’s shareholder disclosure shows that BlackRock Portfolio Management LLC has filed Amendment No. 1 to a Schedule 13G regarding its position in the company’s common stock.
Biophytis SA’s shareholder disclosure shows that BlackRock Portfolio Management LLC has filed Amendment No. 1 to a Schedule 13G regarding its position in the company’s common stock. As of 12/31/2025, BlackRock Portfolio Management LLC reports beneficial ownership of 1,905,946 shares of Biophytis common stock, representing 4.8% of the outstanding class. All of these shares are reported with sole voting and sole dispositive power, with no shared power.
The filing explains that this reflects securities beneficially owned, or deemed beneficially owned, by certain business units of BlackRock, Inc. and its subsidiaries, and excludes other disaggregated business units. It also notes that various underlying persons have rights to dividends or sale proceeds, but no single person has more than five percent of the total outstanding common shares. BlackRock Portfolio Management LLC certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Biophytis SA.
Positive
None.
Negative
None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Biophytis SA (BPTSY) does BlackRock Portfolio Management LLC report?
BlackRock Portfolio Management LLC reports beneficial ownership of 1,905,946 shares of Biophytis SA common stock, representing 4.8% of the outstanding class as of 12/31/2025.
What type of filing did BlackRock Portfolio Management LLC submit for Biophytis SA (BPTSY)?
BlackRock Portfolio Management LLC submitted an Amendment No. 1 to Schedule 13G reporting its beneficial ownership of Biophytis SA common stock.
Does BlackRock Portfolio Management LLC have sole or shared voting power over Biophytis SA (BPTSY) shares?
The filing states that BlackRock Portfolio Management LLC has sole voting power over 1,905,946 shares and no shared voting power in Biophytis SA.
How much dispositive power does BlackRock Portfolio Management LLC have over its Biophytis SA (BPTSY) shares?
BlackRock Portfolio Management LLC reports sole dispositive power over 1,905,946 Biophytis SA common shares and no shared dispositive power.
Is BlackRock Portfolio Management LLC seeking to influence control of Biophytis SA (BPTSY)?
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Biophytis SA.
Who ultimately benefits from the Biophytis SA (BPTSY) shares held by BlackRock Portfolio Management LLC?
The filing notes that various persons have rights to dividends or sale proceeds from Biophytis SA stock, but no single person has an interest exceeding five percent of the total outstanding common shares.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Biophytis SA
(Name of Issuer)
Common Stock
(Title of Class of Securities)
F1022R155
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
F1022R155
1
Names of Reporting Persons
BlackRock Portfolio Management LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
1,905,946.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
1,905,946.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,905,946.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.8 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Biophytis SA
(b)
Address of issuer's principal executive offices:
SORBONNE UNIVERSITY, BC 9, BATIMENT A 4EME ETAGE, 4 PLACE JUSSIEU, PARIS, FRANCE, 75001
Item 2.
(a)
Name of person filing:
BlackRock Portfolio Management LLC
In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
(b)
Address or principal business office or, if none, residence:
BlackRock Portfolio Management LLC, 50 Hudson Yards New York, NY 10001
(c)
Citizenship:
See Item 4 of Cover Page
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
F1022R155
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
1,905,946
(b)
Percent of class:
4.8%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
1,905,946
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
1,905,946
(iv) Shared power to dispose or to direct the disposition of:
0
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of Biophytis SA. No one person's interest in the common stock of Biophytis SA is more than five percent of the total outstanding common shares.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Exhibit 99
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
